BE858520A - Derives de thiazolidine leur procede de preparation leur application en therapeutique - Google Patents

Derives de thiazolidine leur procede de preparation leur application en therapeutique

Info

Publication number
BE858520A
BE858520A BE180769A BE180769A BE858520A BE 858520 A BE858520 A BE 858520A BE 180769 A BE180769 A BE 180769A BE 180769 A BE180769 A BE 180769A BE 858520 A BE858520 A BE 858520A
Authority
BE
Belgium
Prior art keywords
preparation process
therapeutic application
thiazolidine derivatives
thiazolidine
derivatives
Prior art date
Application number
BE180769A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BE858520A publication Critical patent/BE858520A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/45Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by at least one doubly—bound oxygen atom, not being part of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84Naphthothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
BE180769A 1976-09-08 1977-09-08 Derives de thiazolidine leur procede de preparation leur application en therapeutique BE858520A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762640358 DE2640358A1 (de) 1976-09-08 1976-09-08 Thiazolidinderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
BE858520A true BE858520A (fr) 1978-03-08

Family

ID=5987411

Family Applications (1)

Application Number Title Priority Date Filing Date
BE180769A BE858520A (fr) 1976-09-08 1977-09-08 Derives de thiazolidine leur procede de preparation leur application en therapeutique

Country Status (20)

Country Link
US (1) US4174397A (fr)
JP (1) JPS5334771A (fr)
AT (2) AT365181B (fr)
AU (1) AU509651B2 (fr)
BE (1) BE858520A (fr)
CA (1) CA1089458A (fr)
DE (1) DE2640358A1 (fr)
DK (1) DK397777A (fr)
ES (1) ES462065A1 (fr)
FI (1) FI772642A (fr)
FR (1) FR2364219A1 (fr)
GB (1) GB1592272A (fr)
HU (1) HU175751B (fr)
IT (1) IT1084414B (fr)
NL (1) NL7709697A (fr)
NO (1) NO773094L (fr)
NZ (1) NZ185105A (fr)
PT (1) PT67014B (fr)
SE (1) SE7710084L (fr)
ZA (1) ZA775405B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210039A (ja) * 1983-05-16 1984-11-28 Kirin Brewery Co Ltd 2−ブロモ−1−テトラロン誘導体およびその用途
JPS6297769A (ja) * 1985-10-23 1987-05-07 Kobe Steel Ltd 溶接管の製造方法
EP0339978B1 (fr) * 1988-04-28 1996-08-21 Schering Corporation Composés polycycliques condensés, compositions, procédés de préparation et leur utilisation comme agents PAF antagonistiques, antihistaminiques et/ou anti-inflammatoires
DE19736922A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Halogenindan-1-onen
DE19736921A1 (de) * 1997-08-25 1999-03-04 Bayer Ag Verfahren zur Herstellung von 2-Cyanoindan-1-onen
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19844547C2 (de) * 1998-09-29 2002-11-07 Aventis Pharma Gmbh Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908536A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908533A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908538A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908539A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE19908537A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
DE50003761D1 (de) * 1999-11-05 2003-10-23 Aventis Pharma Gmbh Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE10008274A1 (de) * 2000-02-23 2001-08-30 Aventis Pharma Gmbh Substituierte 8,8a-Dihydro-3aH-indeno[1,2-d]thiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
NZ520926A (en) 2000-02-23 2004-08-27 Aventis Pharma Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents
AU2001244136B2 (en) 2000-02-26 2005-04-14 Sanofi-Aventis Deutschland Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, method for production thereof and use thereof as medicament
DE10142722A1 (de) * 2001-08-31 2003-03-27 Aventis Pharma Gmbh C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142661B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel
DE10142667B4 (de) * 2001-08-31 2004-06-09 Aventis Pharma Deutschland Gmbh C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel
DE10142662B4 (de) 2001-08-31 2004-07-08 Aventis Pharma Deutschland Gmbh Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
CN106255676B (zh) * 2014-05-15 2019-04-30 富士胶片株式会社 α-溴代苯乙酮化合物的制造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2436263C2 (de) * 1974-07-27 1983-02-17 Hoechst Ag, 6000 Frankfurt Thiazolidinderivate und Verfahren zu ihrer Herstellung
DE2533821A1 (de) * 1975-07-29 1977-02-17 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
PT67014B (de) 1979-05-14
AT365181B (de) 1981-12-28
DE2640358A1 (de) 1978-03-16
JPS5334771A (en) 1978-03-31
GB1592272A (en) 1981-07-01
DK397777A (da) 1978-03-09
CA1089458A (fr) 1980-11-11
ATA171881A (de) 1984-01-15
FR2364219B1 (fr) 1980-06-20
FR2364219A1 (fr) 1978-04-07
FI772642A (fi) 1978-03-09
SE7710084L (sv) 1978-03-09
NL7709697A (nl) 1978-03-10
ES462065A1 (es) 1978-06-01
HU175751B (hu) 1980-10-28
ATA643577A (de) 1981-05-15
AU509651B2 (en) 1980-05-22
US4174397A (en) 1979-11-13
PT67014A (de) 1977-09-30
NO773094L (no) 1978-03-09
AU2865777A (en) 1979-03-15
ZA775405B (en) 1978-07-26
NZ185105A (en) 1979-12-11
IT1084414B (it) 1985-05-25

Similar Documents

Publication Publication Date Title
BE858520A (fr) Derives de thiazolidine leur procede de preparation leur application en therapeutique
BE865632A (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2387234B1 (fr) Derives de cephalosporine, leur procede de preparation et leurs applications en therapeutique
BE849794A (fr) Derives de carbostyrile et leur procede de preparation
FR2383157B1 (fr) Derives de chalcone, leur procede de preparation et leur application en therapeutique
BE867421A (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
BE850401A (fr) Derives de phtalane et procede de preparation
FR2340950A1 (fr) Esters du cefuroxime, leur procede de preparation et leur application en therapeutique
FR2343748A1 (fr) Derives de 2,3-dihydro imidazo (2,1-b) thiazole, leur procede de preparation et leur application en therapeutique
FR2349579A1 (fr) Derives de 1,2-dihydronaphtalene et leur procede de preparation
BE822616A (fr) Derives de 7alpha-methoxycephalosporine leur procede de preparation et leur application therapeutique
BE862785A (fr) Derives de pyrimido(6,1-a)isoquinoleine-2-one, leur procede de preparation et leur application en therapeutique
FR2299032A1 (fr) Derives de tetrahydroisoquinoleine et leur procede de preparation
FR2319345A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application
BE850575A (fr) Des derives de thiazolidine leur procede preparation et leurs applications
FR2315925A1 (fr) Nouveaux derives de 5-benzyle-2-oxazolidone, leur procede de preparation et leur application en therapeutique
BE866676A (fr) Derives de bisamidine, leur procede de preparation et leur application therapeutique
BE827870A (fr) Derives d'emidazole et leur procede de preparation
FR2351965A1 (fr) Benzenesulfonylurees, leur procede de preparation et leur application therapeutique
FR2313063A1 (fr) Derives de pyrrolotriazolopyrimidine leur procede de preparation et leurs applications en therapeutique
BE883713A (fr) Nouveau derives de carbostyrile, leur procede de preparation et leur application en therapeutique
BE870987A (fr) Nouveaux derives du benzo (d) thiazole, leur procede de preparation et leurs applications en therapeutique
BE882270A (fr) Derives de benzothiazole, leur procede de preparation et leurs applications en therapeutique
PT68267A (fr) Procede de preparation de derives d'oxadiazole-1,2,4 et leur application en therapeutique
FR2351098A1 (fr) Derives de l'isothiouree, leur procede de preparation et leur application therapeutique